SCHEMBL27274598

SCHEMBL27274598

C=C(C)C1CN(CC2CCCC2)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM5 P08912 2/20 0.43
▸ ADRA2C P18825 1/20 0.43
▸ GBA1 P04062 1/20 0.43
▸ ACHE P22303 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ SCN1A P35498 1/20 0.37
▸ SCN4A P35499 1/20 0.37
▸ SCN7A Q01118 1/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ SCN5A Q14524 1/20 0.37
▸ SCN9A Q15858 1/20 0.37
▸ SCN2A Q99250 1/20 0.37
▸ SCN3A Q9NY46 1/20 0.37
▸ SCN11A Q9UI33 1/20 0.37
▸ SCN8A Q9UQD0 1/20 0.37
▸ SCN10A Q9Y5Y9 1/20 0.37
▸ SIGMAR1 Q99720 2/20 0.37
▸ CHRM2 P08172 1/20 0.34
▸ CHRM4 P08173 1/20 0.34
▸ CHRM1 P11229 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20438228 0.76 SMN1; SMN2 (0.42) CHRM5ADRA2CGBA1ACHESMN1; SMN2
SCHEMBL13905846 0.73 SMN1; SMN2 (0.47) CHRM5ADRA2CGBA1ACHESMN1; SMN2
SCHEMBL13905729 0.72 SMN1; SMN2 (0.50) CHRM5ADRA2CGBA1ACHESMN1; SMN2
SCHEMBL23441833 0.69 SCN1A (0.38) CHRM5ADRA2CGBA1ACHESCN1A
SCHEMBL17873962 0.69 SMN1; SMN2 (0.43) CHRM5ADRA2CGBA1SMN1; SMN2SCN1A
SCHEMBL10509286 0.68 GBA1 (0.56) CHRM5ADRA2CGBA1ACHESMN1; SMN2
SCHEMBL1437686 0.67 — —
SCHEMBL24256245 0.67 GBA1 (0.60) CHRM5ADRA2CGBA1ACHESMN1; SMN2
SCHEMBL24491906 0.67 CHRM5 (0.46) CHRM5ADRA2CGBA1ACHESMN1; SMN2
SCHEMBL24491581 0.67 CHRM5 (0.46) CHRM5ADRA2CGBA1ACHESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024036254-A2 SYNTHETIC PROCESSES AND INTERMEDIATES FOR PREPARING THERAPEUTIC AZAKETOLIDES ZIKANI THERAPEUTICS, INC. (US) 2024-02-15 — — WO disclosed
Send feedback